Transcode Therapeutics (RNAZ) Gains from Investment Securities (2020 - 2026)
Transcode Therapeutics' (RNAZ) quarterly Gains from Investment Securities came in at -$116000.0 in Q1 2026, down 101.26% YoY from $9.2 million in Q1 2025, and up 70.89% on a QoQ basis from -$398476.0 in Q4 2025.
Transcode Therapeutics (RNAZ) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Transcode Therapeutics (RNAZ) has 4 years of Gains from Investment Securities data on file, last reported at -$116000.0 in Q1 2026.
- Quarterly Gains from Investment Securities fell 101.26% year-over-year to -$116000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73601.0 (down 100.8% YoY) and the FY2025 annual result came in at $9.3 million, up 888.33% from the prior year.
- Gains from Investment Securities grew to -$116000.0 in Q1 2026, from -$398476.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.2 million in Q1 2025 to a low of -$398476.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Transcode Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116,000.00 |
| Mar 31, 2026 | -116,000.00 |
| Dec 31, 2025 | -398,476.00 |
| Dec 31, 2025 | -398,476.00 |
| Sep 30, 2025 | 279,161.00 |
| Sep 30, 2025 | 279,161.00 |
| Jun 30, 2025 | 161,714.00 |
| Jun 30, 2025 | 161,714.00 |
| Mar 31, 2025 | 9.23 Mn |
| Mar 31, 2025 | 9.23 Mn |
| Sep 30, 2021 | 1,340.00 |
| Sep 30, 2021 | 1,340.00 |
| Jun 30, 2021 | -42,346.00 |
| Jun 30, 2021 | -42,346.00 |
| Mar 31, 2021 | 47,115.00 |
| Mar 31, 2021 | 47,115.00 |
| Dec 31, 2020 | 688.00 |
| Dec 31, 2020 | 688.00 |
| Sep 30, 2020 | 14,164.00 |
| Sep 30, 2020 | 14,164.00 |